1. |
2. Asertivnost in zdravstvoMaša Černelič Bizjak, 2009, review article Abstract: Prispevek obravnava konstrukt asertivnosti. Predstavljene so definicije in koncepcije asertivnosti, njene komponente ter merjenje asertivnosti. Povzeti so tudi rezultati raziskav, ki ugotavljajo povezanost z različnimi psihološkimi konstrukti. Posebej je obravnavan pomen asertivnosti z vidika pacienta in z vidika medicinske sestre. Študije v glavnem poudarjajo in potrjujejo potrebo medicinskih sester po učenju asertivnih veščin, saj le-te delujejo kot zaščita pred emocionalno izčrpanostjo, stresom in izgorelostjo, ki je pogosto omenjena posledica dela na delovnem mestu medicinske sestre.
Keywords: asertivnost, aktivni pacienti, medicinske sestre, agresivnost, submisivnost
Published in DiRROS: 28.01.2026; Views: 282; Downloads: 0 |
3. Influenza vaccine uptake in juvenile idiopathic arthritis during the COVID-19 pandemic : a multi-centre cross-sectional study by PRES vaccination working partyDespoina Maritsi, Noa Alpert, Maša Bizjak, Amit Ziv, Barbora Balažiová, Nataša Toplak, 2025, other scientific articles Abstract: Background: Children with rheumatic diseases are at risk for contracting severe influenza and COVID-19 and are thus targeted for these vaccination. Objectives: To assess the influenza (flu) vaccination rate in children with Juvenile Idiopathic Arthritis (JIA), investigate families’ attitudes towards the influenza vaccine, and the effect of the COVID-19 pandemic on flu vaccine uptake. Methods: This multi-centre, cross-sectional study was conducted across 9 countries. JIA caregivers completed an anonymous questionnaire about their children’s influenza vaccination, including the 2019–2020 and 2020–2021 seasons, including knowledge, and perceptions regarding influenza vaccination. Results: Based on responses from 655 JIA caregivers, 152 children (23.2%) received influenza vaccinations in the 2020–2021 season, representing a significant rise from 18.6% in the previous season (p < 0.01). The likelihood of vaccination was higher among employed/self-employed caregivers compared to unemployed (28.2% and 29.9% vs. 13.9%), and those with tertiary education versus elementary (28% vs. 9.7%), both p < 0.01. Concerns of children’s vulnerability to SARS-CoV-2 and severe COVID-19 disease due to JIA were prevalent (51.3% and 85.3% respectively), with 51.3% supporting COVID-19 vaccination. Caregivers who previously vaccinated their children for influenza showed a greater inclination towards SARS-CoV-2 vaccination (73.4% and 79.5%, p < 0.01). Conclusions: Families of children with JIA reported an increasing flu vaccine uptake and a high intention for COVID- 19 vaccine administration. Previous vaccination behavior was shown as a significant predictor of future behaviour. Strengthening health education may address fears and lead to better vaccine coverage against both influenza and SARS-CoV-2 in children with JIA and other inflammatory rheumatic diseases.
Keywords: influenza vaccine, juvenile idiopathic arthritis, JIA, COVID-19, vaccination, children
Published in DiRROS: 09.12.2025; Views: 632; Downloads: 314
 Full text (956,89 KB)
This document has many files! More... |
4. Safety, long-term effectiveness, and immunogenicity of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapyMaša Bizjak, Jakob Peterlin, Tadej Avčin, Miroslav Petrovec, Alojz Ihan, Mojca Zajc Avramovič, Gašper Markelj, Tina Vesel, Veronika Osterman, Jerneja Ahčan, Helena Mole, Katja Dejak Gornik, Alenka Biteznik, Sara Jevnikar, Larisa Janžič, Miha Bajc, Andreja Nataša Kopitar, Nataša Toplak, 2025, original scientific article Abstract: Objective: To evaluate safety, long-term effectiveness and immunogenicity of varicella vaccination in children with JIA, treated with biologic disease-modifying antirheumatic drugs (bDMARDs). Methods: This is a prospective case-control study. VZV-naive patients with JIA on selected bDMARDs (TNFi, IL-6 and IL-1 inhibitors), who were at risk for contracting varicella, had stable disease and normal values of immunoglobulins and lymphocyte populations, were vaccinated against varicella. Adverse events (AEs) and disease activity were followed after vaccination. VZV-specific humoral (VZV-IgG) and cell-mediated immunity (VZV-CMI) were measured at predetermined time points after vaccination by Liaison and intracellular cytokine staining, respectively. Two healthy control (HC) groups comprised 52 healthy children after varicella vaccination and 69 healthy children after varicella infection. Results: 17 patients were vaccinated against varicella (12 on TNFi, 4 on IL-6 inhibitors and 1 on IL-1 inhibitor), of whom 14 patients received both the first and second dose on bDMARDs. No vaccine-strain infections or other serious AEs occurred after vaccination. Disease activity increased in 3/17 (18 %) patients following vaccination. Four out of 17 (24 %) patients developed mild breakthrough varicella (BV) 4 months-4.5 years after vaccination, and none of the HC. Fourteen out of 17 (82 %) patients and 50/52 (96 %) vaccinated HC were seropositive after second vaccination and 8/11 (72 %) patients and 42/43 (98 %) vaccinated HC developed VZV-CMI, which persisted longer compared to VZV-IgG. Patients presented lower antibody levels compared to HC. The rate of VZV-IgG decline was comparable between patients and HC after vaccination or infection. Five patients received the third vaccine dose due to primary or secondary vaccine failure, and none of them developed BV. Conclusions: Varicella vaccination was safe and largely immunogenic in our cohort of JIA patients treated with bDMARDs. Although the vaccination was not always fully effective, it prevented severe disease in all vaccinated patients.
Keywords: varicella vaccination, juvenile idiopathic arthritis, biologic therapy, anti-cytokine therapy
Published in DiRROS: 13.11.2025; Views: 513; Downloads: 298
Full text (2,05 MB)
This document has many files! More... |
5. Disordered eating attitudes, depressive symptomatology and alcohol consumption in young athletesUroš Perko, Maša Černelič Bizjak, 2022, original scientific article Abstract: Purpose: The aim of the study was to investigate the prevalence of disordered ea-ting behaviours and attitudes in Slovenian male and female categorized athletes in relation to depressive symptoms and their alcohol consumption. Methods: The sample included 198 categorized athletes between 18 and 20 years of age. The Eating Attitude Test, the Center for Epidemiologic Studies Depression Scale, and the Alcohol Use Disorders Identification Test were used to measure disordered eating behaviours, level of depression, and alcohol use, respectively.Results: Significant differences were found between female and male at-hletes, with female athletes reporting higher levels of disordered eating atti-tudes and depressive symptoms. 13.90% of athletes reported clinically signi-ficant eating disorder symptoms, 40% reported clinically significant depres-sive symptoms, and 10.50% reported risky alcohol use.Results also showed that athletes with higher eating disorder attitudes had higher depressive levels.Conclusion: These findings have important practical value and point to the importance of building a professional team trained to recognize mental health problems in athletes in order to provide appropriate help.
Keywords: disordered eating behaviours, athletes, depression, alcohol consumption
Published in DiRROS: 15.04.2024; Views: 1320; Downloads: 773
Full text (533,58 KB)
This document has many files! More... |
